| Symbol |
Name |
Standardized Value |
|
PAX5
|
paired box 5
|
1.66149
|
|
CD5
|
CD5 molecule
|
1.62963
|
|
PAX2
|
paired box 2
|
1.44782
|
|
MYD88
|
myeloid differentiation primary response 88
|
1.26211
|
|
CD38
|
CD38 molecule
|
1.08537
|
|
SLC35B2
|
solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B2
|
1.0837
|
|
CD19
|
CD19 molecule
|
1.07194
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
1.03198
|
|
IGHV1-2
|
immunoglobulin heavy variable 1-2
|
0.996549
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
0.995283
|
|
CCND1
|
cyclin D1
|
0.983479
|
|
IGHV5-51
|
immunoglobulin heavy variable 5-51
|
0.93
|
|
CD22
|
CD22 molecule
|
0.926279
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
0.895
|
|
CD52
|
CD52 molecule
|
0.862228
|
|
MALT1
|
MALT1 paracaspase
|
0.815514
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
0.80977
|
|
IRF4
|
interferon regulatory factor 4
|
0.759416
|
|
CD200
|
CD200 molecule
|
0.738271
|
|
CD27
|
CD27 molecule
|
0.714005
|
|
MNDA
|
myeloid cell nuclear differentiation antigen
|
0.684692
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
0.65565
|
|
BCL9
|
B-cell CLL/lymphoma 9
|
0.640251
|
|
IGHA1
|
immunoglobulin heavy constant alpha 1
|
0.607714
|
|
APCS
|
amyloid P component, serum
|
0.567997
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
0.559062
|
|
CLCN6
|
chloride channel, voltage-sensitive 6
|
0.539667
|
|
DFFB
|
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)
|
0.536957
|
|
IGHV4-34
|
immunoglobulin heavy variable 4-34
|
0.529222
|
|
CA14
|
carbonic anhydrase XIV
|
0.508041
|
|
SIGLEC10
|
sialic acid binding Ig-like lectin 10
|
0.491597
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
0.461261
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
0.459751
|
|
FMOD
|
fibromodulin
|
0.446182
|
|
KMT2B
|
lysine (K)-specific methyltransferase 2B
|
0.437906
|
|
SLC3A2
|
solute carrier family 3 (amino acid transporter heavy chain), member 2
|
0.406425
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
0.406051
|
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate
|
0.398216
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
0.382223
|
|
PGLS
|
6-phosphogluconolactonase
|
0.382223
|
|
IGLV7-43
|
immunoglobulin lambda variable 7-43
|
0.369628
|
|
IGHV4-39
|
immunoglobulin heavy variable 4-39
|
0.360026
|
|
NBN
|
nibrin
|
0.35892
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
0.334681
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
0.333949
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
0.322273
|
|
ATM
|
ATM serine/threonine kinase
|
0.321545
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
0.319726
|
|
IGHV3-9
|
immunoglobulin heavy variable 3-9
|
0.300173
|
|
PGM1
|
phosphoglucomutase 1
|
0.284013
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
0.283297
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
0.268687
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
0.255594
|
|
MLLT1
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1
|
0.248203
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
0.235616
|
|
B2M
|
beta-2-microglobulin
|
0.234573
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
0.221108
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
0.215992
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
0.215653
|
|
CHEK2
|
checkpoint kinase 2
|
0.206913
|
|
DAPK1
|
death-associated protein kinase 1
|
0.188632
|
|
IGH
|
immunoglobulin heavy locus
|
0.182666
|
|
CD1D
|
CD1d molecule
|
0.176757
|
|
ETV6
|
ets variant 6
|
0.166095
|
|
SDC1
|
syndecan 1
|
0.161716
|
